戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ia guyanensis , Leishmania amazonensis , and Trypanosoma cruzi .
2 ureus), a virus (influenza), and a parasite (Trypanosoma cruzi).
3 potentially foodborne parasites (for example Trypanosoma cruzi).
4 viduals infected with the protozoan parasite Trypanosoma cruzi.
5 mmunity following intradermal infection with Trypanosoma cruzi.
6 ection caused by the intracellular protozoan Trypanosoma cruzi.
7 s' disease, caused by the protozoan parasite Trypanosoma cruzi.
8 y infection caused by the protozoan parasite Trypanosoma cruzi.
9 cal disease caused by the protozoan parasite Trypanosoma cruzi.
10 tes of Leishmania major and epimastigotes of Trypanosoma cruzi.
11 atin America that is caused by the protozoan Trypanosoma cruzi.
12  T. brucei bloodstream forms, Leishmania and Trypanosoma cruzi.
13  disease is caused by the protozoan parasite Trypanosoma cruzi.
14 Rs, are highly susceptible to infection with Trypanosoma cruzi.
15 S) and inflammatory cytokines in response to Trypanosoma cruzi.
16 gas disease caused by the protozoan parasite Trypanosoma cruzi.
17 sed by infection with the protozoan parasite Trypanosoma cruzi.
18 d as a regulator of stage differentiation in Trypanosoma cruzi.
19 has been implemented for West Nile virus and Trypanosoma cruzi.
20 ase is caused by infection with the parasite Trypanosoma cruzi.
21 rucial for control of the protozoan parasite Trypanosoma cruzi.
22 asitemia and mortality in mice infected with Trypanosoma cruzi.
23  easy discrimination of Leishmania major and Trypanosoma cruzi.
24 n the infective stages of the human parasite Trypanosoma cruzi.
25 CI 2.2-6.8) were estimated to be infected by Trypanosoma cruzi.
26 the kinetoplastidea including Leishmania and Trypanosoma cruzi.
27 used by the kinetoplastid protozoan parasite Trypanosoma cruzi.
28 the authors present a 2.5-A structure of the Trypanosoma cruzi 60S ribosomal subunit and propose a mo
29                                              Trypanosoma cruzi, a parasite that causes Chagas' diseas
30               The in vitro and in vivo anti- Trypanosoma cruzi activity of the pyrazole-containing ma
31 re than 20 outstanding derivatives with anti-Trypanosoma cruzi activity.
32 ith selective and significant in vitro anti- Trypanosoma cruzi activity.
33    Chagas disease is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwid
34 as disease, caused by the protozoan parasite Trypanosoma cruzi, affects 7 million people in Latin Ame
35 ease, caused by the hemoflagellate protozoan Trypanosoma cruzi, affects millions of people in South a
36 gas disease is a chronic infection caused by Trypanosoma cruzi, an intracellular protozoan parasite.
37  disease is caused by the protozoan parasite Trypanosoma cruzi and affects 5-8 million people in Lati
38  time for the simultaneous detection of anti-Trypanosoma cruzi and anti-Leishmania infantum antibodie
39     Chagas disease is caused by the parasite Trypanosoma cruzi and is an important cause of morbidity
40 ago, is caused by the intracellular parasite Trypanosoma cruzi and is most frequently associated with
41 s of the human parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania major.
42 rasite genome sequences: Trypanosoma brucei, Trypanosoma cruzi and Leishmania major.
43 have been considered as virulence factors of Trypanosoma cruzi and Leishmania spp., and have been dem
44 gondii and kinetoplastid protozoa, including Trypanosoma cruzi and Leishmania spp., cause millions of
45  interactions between the protozoan parasite Trypanosoma cruzi and mammalian hosts at primary sites o
46 e is a chronic infection in humans caused by Trypanosoma cruzi and manifested in progressive cardiomy
47 rified Complex II from the parasitic protist Trypanosoma cruzi and obtained the unexpected result tha
48 mans: Toxoplasma gondii, Trypanosoma brucei, Trypanosoma cruzi and Plasmodium falciparum.
49      Entamoeba histolytica, Leishmania spp., Trypanosoma cruzi and Trichomonas vaginalis have genes e
50                                              Trypanosoma cruzi and Trypanosoma brucei are parasites t
51  to human disease, i.e. Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
52 ng the etiological agents of Chagas disease (Trypanosoma cruzi) and African sleeping sickness (Trypan
53  disease is caused by the protozoan parasite Trypanosoma cruzi, and activation of CD8(+) T cells is c
54 in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diph
55 strate binding cavities (Trypanosoma brucei, Trypanosoma cruzi, and L. infantum) suggests that substr
56 d pathogens (Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani), and several
57 d pathogens (Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani), and two com
58 logues in the genomes of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major were identified.
59 infections due to Toxoplasma gondii (n = 3), Trypanosoma cruzi, and Leishmania species.
60  the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp.
61      The trypanosomatids Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp. are flagellate eu
62 lude the human pathogens Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp., which in humans
63  array, with emphasis on Trypanosoma brucei, Trypanosoma cruzi, and Leishmania, which cause life-thre
64  of the trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, and Leishmania.
65 asitic pathogens including Leishmania major, Trypanosoma cruzi, and Neisseria gonorrhoeae.
66 mes have been studied in Trypanosoma brucei, Trypanosoma cruzi, and various Leishmania species.
67 ther eukaryotes, the protein-coding genes of Trypanosoma cruzi are arranged in large polycistronic ge
68                            Brucella spp. and Trypanosoma cruzi are two intracellular pathogens that h
69 centrating on Mycobacterium tuberculosis and Trypanosoma cruzi as examples of bacterial and parasitic
70 ng infection with the intracellular parasite Trypanosoma cruzi, as evidenced by transcriptome and cyt
71                                          The Trypanosoma cruzi ascorbate peroxidase is, by sequence a
72 protein (FCaBP) of the flagellated protozoan Trypanosoma cruzi associates with the flagellar membrane
73                  Several compounds that kill Trypanosoma cruzi at subnanomolar concentrations and are
74 NF) produced by the Chagas' disease parasite Trypanosoma cruzi binds nerve growth factor (NGF) recept
75 bolically challenged and upon infection with Trypanosoma cruzi (Brazil strain) suffer high mortality.
76 linical trials, was previously found to kill Trypanosoma cruzi by blocking sterol 14 alpha-demethylas
77 tually enhances infection with the protozoan Trypanosoma cruzi, by a mechanism that may involve facil
78 kills the causative agent of Chagas disease, Trypanosoma cruzi, by blocking ergosterol biosynthesis a
79 ole and posaconazole have not been tested in Trypanosoma cruzi carriers.
80                                              Trypanosoma cruzi causes American trypanosomiasis, where
81                                              Trypanosoma cruzi causes Chagas disease (American trypan
82 examined the Leishmania major (Friedlin) and Trypanosoma cruzi (CL Brener) genome projects for SL RNA
83                 The Chagas' disease parasite Trypanosoma cruzi commonly infects humans through skin a
84                         The protozoan agent, Trypanosoma cruzi, comprises six genetic lineages, TcI-T
85 mania species, unlike Trypanosoma brucei and Trypanosoma cruzi, contain genes encoding MTHFR and two
86 aminopyridyl-based lead inhibitors targeting Trypanosoma cruzi CYP51 (TcCYP51) has been developed usi
87 reference perspective, cruzain, an essential Trypanosoma cruzi cysteine protease, is highly homologou
88         Activation of innate immune cells by Trypanosoma cruzi-derived molecules such as GPI anchors
89 rom the parasite that causes Chagas disease, Trypanosoma cruzi, directly in whole, unprocessed human
90 he pathogenic species Trypanosoma brucei and Trypanosoma cruzi, edit their post-transcriptional mitoc
91        Loss of a single copy of this gene in Trypanosoma cruzi, either through in vitro drug selectio
92                 The Chagas' disease parasite Trypanosoma cruzi elicits a potent inflammatory response
93                   The genome of the parasite Trypanosoma cruzi encodes two copies of autophagy-relate
94  by the oligosaccharyltransferase (OST) from Trypanosoma cruzi, Entamoeba histolytica, Trichomonas va
95                      To successfully infect, Trypanosoma cruzi evades and modulates the host immune r
96           In contrast, as a model eukaryote, Trypanosoma cruzi exhibits two individual putative ortho
97 n, purification, and characterization of the Trypanosoma cruzi exopolyphosphatase (TcPPX).
98                                The protozoan Trypanosoma cruzi expresses multiple isoforms of the GP6
99  PDNF, produced by the Chagas' disease agent Trypanosoma cruzi, functionally mimics mammalian neurotr
100 s a putative nucleoside phosphorylase in the Trypanosoma cruzi genome was overexpressed in Escherichi
101  is shown to be a highly potent inhibitor of Trypanosoma cruzi growth (ED(50) = 4 nM).
102                                The protozoan Trypanosoma cruzi has a complicated dual-host life cycle
103 e extreme genetic diversity of the protozoan Trypanosoma cruzi has been proposed to be associated wit
104                       The protozoan parasite Trypanosoma cruzi has evolved sophisticated systems to e
105                         The protist parasite Trypanosoma cruzi has evolved the ability to transit bet
106                         Oral transmission of Trypanosoma cruzi has gained relevance because of its as
107       Recent discussions on the evolution of Trypanosoma cruzi have been dominated by the southern su
108                    Finally, we show that the Trypanosoma cruzi homologue of PrpA also targets macroph
109  presumably by keeping the etiological agent Trypanosoma cruzi in check through protective immunity a
110  The journey of the Chagas' disease parasite Trypanosoma cruzi in the human body usually starts in th
111                                              Trypanosoma cruzi-induced inflammatory pathology and a f
112                               Infection with Trypanosoma cruzi induces inflammation, which limits par
113 ar why only a proportion of children born to Trypanosoma cruzi-infected mothers acquire the infection
114 ivities (39 to 58%) and ATP (38%) content in Trypanosoma cruzi-infected murine hearts compared with n
115  of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-infected persons.
116 ongenital transmission and cardiomyopathy in Trypanosoma cruzi-infected women.
117 patients with suspected or confirmed chronic Trypanosoma cruzi infection (Chagas disease).
118                                              Trypanosoma cruzi infection (which causes Chagas disease
119                     Vertical transmission of Trypanosoma cruzi infection accounts for a growing propo
120                                   Congenital Trypanosoma cruzi infection accounts for an estimated 22
121 response plays a crucial role in controlling Trypanosoma cruzi infection and parasite burden, but it
122 nic epithelial model HCT116 cells respond to Trypanosoma cruzi infection by secreting defensin alpha-
123                The innate immune response to Trypanosoma cruzi infection comprises several pattern re
124 at immune responses in subjects with chronic Trypanosoma cruzi infection display features common to o
125                                              Trypanosoma cruzi infection drives the expansion of rema
126    Increasingly during the past few decades, Trypanosoma cruzi infection has been detected in North A
127 mmunochromatographic dipstick test to detect Trypanosoma cruzi infection in 366 human serum samples w
128 or T-bet (Tbx21) regulates Th17 responses to Trypanosoma cruzi infection in an IFN-gamma-independent
129                                   We studied Trypanosoma cruzi infection in mice in which NRF2/HO-1 w
130 city and equivalent or improved efficacy for Trypanosoma cruzi infection is a priority.
131                                              Trypanosoma cruzi infection leads to development of a ch
132 loss of certain functional activities during Trypanosoma cruzi infection might result in the inabilit
133  to reach cardiac tissue in vivo, even after Trypanosoma cruzi infection, a known inducer of lymphoid
134 ion of Th17 cells, we used a murine model of Trypanosoma cruzi infection, a protozoan parasite that c
135 nic Chagas disease cardiomyopathy, caused by Trypanosoma cruzi infection, is a major cause of heart f
136                                   In chronic Trypanosoma cruzi infection, the cause of Chagas disease
137                             Using a model of Trypanosoma cruzi infection, we demonstrate that in cont
138 tablishing a system for drug cure of chronic Trypanosoma cruzi infection, we present the first extens
139                                              Trypanosoma cruzi infection, which is the etiological ag
140 uestions in detail using the murine model of Trypanosoma cruzi infection.
141 afety of benznidazole in adults with chronic Trypanosoma cruzi infection.
142 e tissue (WAT) and adipocytes are targets of Trypanosoma cruzi infection.
143 CD8(+) T cells are essential for controlling Trypanosoma cruzi infection.
144 o be relevant in the context of experimental Trypanosoma cruzi infection.
145 eviously described in immune response during Trypanosoma cruzi infection.
146 ine protease cruzipain (Cz) protects against Trypanosoma cruzi infection.
147                                   In chronic Trypanosoma cruzi infections, parasite burden is control
148                                              Trypanosoma cruzi infects many cell types but preferenti
149                                              Trypanosoma cruzi infects millions of people in Latin Am
150 oles) displayed significant activity against Trypanosoma cruzi intracellular amastigotes (IC(50) rang
151                     Chagas disease caused by Trypanosoma cruzi is a paradigmatic example of a chronic
152                                              Trypanosoma cruzi is a protozoan parasite that can initi
153                                              Trypanosoma cruzi is a protozoan parasite that causes hu
154                                              Trypanosoma cruzi is a unicellular parasite and the etio
155                                              Trypanosoma cruzi is an intracellular parasite and the c
156                                              Trypanosoma cruzi is an intracellular protozoan parasite
157                                              Trypanosoma cruzi is an intracellular protozoan parasite
158 om basic amino acids, the protozoan parasite Trypanosoma cruzi is incapable of polyamine biosynthesis
159 flagellar calcium-binding protein (FCaBP) of Trypanosoma cruzi is localized to the flagellar membrane
160 ium-binding protein (FCaBP) of the protozoan Trypanosoma cruzi is targeted to the flagellar membrane
161             The parasitic protozoan organism Trypanosoma cruzi is the causative agent of Chagas disea
162    The insect-transmitted protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disea
163                                              Trypanosoma cruzi is the causative agent of chronic chag
164                                              Trypanosoma cruzi is the causative pathogen of Chagas di
165                                              Trypanosoma cruzi is the etiologic agent of Chagas disea
166                                              Trypanosoma cruzi is the etiologic agent of Chagas' dise
167                                              Trypanosoma cruzi is the etiological agent of Chagas dis
168                                              Trypanosoma cruzi is wrapped by a dense coat of mucin-ty
169 sed by infection with the protozoan parasite Trypanosoma cruzi, is a leading cause of heart disease (
170                    Chagas disease, caused by Trypanosoma cruzi, is a major public health issue.
171 used by the intracellular protozoan parasite Trypanosoma cruzi, is a public health problem affecting
172       Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious health problem in Latin
173 aused by the eukaryotic (protozoan) parasite Trypanosoma cruzi, is an alarming emerging global health
174                    Chagas disease, caused by Trypanosoma cruzi, is an important cause of morbidity an
175 ysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chaga
176      Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affec
177       Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America.
178 me found in parasitic Leishmania species and Trypanosoma cruzi, is implicated in deglutathionylation
179 s' disease, caused by the protozoan parasite Trypanosoma cruzi, is the most common cause of cardiac-r
180  heart disease (CHD), caused by the parasite Trypanosoma cruzi, is the most common form of myocarditi
181  are highly conserved in clinically relevant Trypanosoma cruzi isolates and are recognized by B and T
182 umber of dialkyl imidazoles as inhibitors of Trypanosoma cruzi lanosterol-14alpha-demethylase (L14DM)
183  of intracellular infection by the protozoan Trypanosoma cruzi leads to the development of human Chag
184  parasites: Trypanosoma brucei rhodesiense , Trypanosoma cruzi , Leishmania donovani , and P. falcipa
185 y infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma bruce
186  cellular effects at different stages of the Trypanosoma cruzi life cycle, the structural data provid
187 or Chagas' disease, we evaluated against all Trypanosoma cruzi life stages the in vitro trypanocidal
188 hmania-like flagellum attachment zone, and a Trypanosoma cruzi-like cytostome are ancestral features,
189 a novel mechanism used by diverse pathogens (Trypanosoma cruzi, Listeria monocytogenes, and adenoviru
190                 Intracellular parasites like Trypanosoma cruzi may also provide new insights into ove
191 ence for a novel immune evasion mechanism of Trypanosoma cruzi, mediated by host cell plasma membrane
192           During experimental infection with Trypanosoma cruzi, mice develop a strong CD8(+) T cell r
193  of the protozoans Leishmania tarentolae and Trypanosoma cruzi mitoribosomes.
194 896 patients; 60.5% had positive results for Trypanosoma cruzi on PCR.
195 no significant activity was detected against Trypanosoma cruzi or Leishmania donovani.
196 rom MIIG mice were unable produce NO or kill Trypanosoma cruzi or Leishmania major after priming with
197         This approach also revealed that the Trypanosoma cruzi ortholog (TcSLS1) is a dedicated inosi
198         A century after discovering that the Trypanosoma cruzi parasite is the etiological agent of C
199                    Chagas disease, caused by Trypanosoma cruzi parasite, was described thousands of y
200                                              Trypanosoma cruzi parasites are the causative agents of
201                             The diversity of Trypanosoma cruzi parasites infecting humans is still po
202 an pathogen Trypanosoma brucei gambiense and Trypanosoma cruzi parasites.
203 mice with the myotropic Colombiana strain of Trypanosoma cruzi, parasites persisted in tissue at low
204 the structures of Leishmania major PDEB1 and Trypanosoma cruzi PDEC.
205  and virulence of Trypanosoma brucei and, in Trypanosoma cruzi, PDEC2 was shown to be required for no
206                                              Trypanosoma cruzi phosphodiesterase C (TcrPDEC) is a pot
207                                     A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid modified in
208                           A newly discovered Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid modified in
209                                     A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid-modified in
210 ro against T rypanosoma brucei rhodesiense , Trypanosoma cruzi , Plasmodium falciparum , and Leishman
211 ork was to analyze the predictive value of a Trypanosoma cruzi-positive polymerase chain reaction (PC
212    EbS was more toxic for T. brucei than for Trypanosoma cruzi, probably due to lower levels of TryR
213 e infectious stage of the protozoan parasite Trypanosoma cruzi produces a surface-anchored complement
214  eukaryotic parasites Trypanosoma brucei and Trypanosoma cruzi provide a first structural view of a e
215 s were identified as potential inhibitors of Trypanosoma cruzi replication, a parasite responsible fo
216         AdoMetDC from the protozoal parasite Trypanosoma cruzi requires putrescine for maximal enzyme
217     Immune control of the protozoan parasite Trypanosoma cruzi requires the activation of both CD4+ a
218 uM against neglected Chagas' disease causing Trypanosoma cruzi, respectively.
219        Infection with the protozoan parasite Trypanosoma cruzi results in a robust and multifaceted i
220 sceptible mice with the Colombiana strain of Trypanosoma cruzi results in an orchestrated expression
221 es, we determined the 2.5-A structure of the Trypanosoma cruzi ribosome large subunit by single-parti
222             Experimental animals infected by Trypanosoma cruzi showed an early rise in myocardial and
223                                              Trypanosoma cruzi species is categorized into six discre
224  in the activation and functional profile of Trypanosoma cruzi-specific DN T cells.
225 rystal structures of the drug target enzyme, Trypanosoma cruzi sterol 14alpha-demethylase (CYP51), co
226 s from a screen against the related parasite Trypanosoma cruzi Subsequent optimization of the chemica
227  expressed in the heart after infection with Trypanosoma cruzi, suggesting that they play an importan
228                      The mechanisms by which Trypanosoma cruzi survives antimicrobial peptides and di
229 c fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi ( T. cruzi ), the causative agent of C
230                                              Trypanosoma cruzi (T. cruzi) infection is endemic in Lat
231 as disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is an increasing threat to
232                                              Trypanosoma cruzi (TC) causes Chagas disease, which in i
233 om the enzymes of Homo sapiens (Hs-SAHH) and Trypanosoma cruzi (Tc-SAHH) are qualitatively similar bu
234 Homo sapiens (Hs-SAHH) and from the parasite Trypanosoma cruzi (Tc-SAHH) are very similar in structur
235 hibitors of the carbonic anhydrase (CA) from Trypanosoma cruzi (TcCA).
236 gas disease, sterol 14alpha-demethylase from Trypanosoma cruzi (TCCYP51), was found to be catalytical
237  bound to a distinctive Argonaute protein of Trypanosoma cruzi, TcPIWI-tryp.
238  vector-borne pathogens, with the example of Trypanosoma cruzi (the etiological agent of Chagas disea
239 re effective agents against proliferation of Trypanosoma cruzi , the etiologic agent of American tryp
240  of fire ants against the protozoan parasite Trypanosoma cruzi, the aetiologic agent of Chagas diseas
241              The Triatominae are vectors for Trypanosoma cruzi, the aetiological agent of the neglect
242                                              Trypanosoma cruzi, the agent of Chagas disease, does not
243                                              Trypanosoma cruzi, the agent of Chagas' disease, infects
244                                              Trypanosoma cruzi, the agent of Chagas' disease, promote
245 f a number of protozoan pathogens, including Trypanosoma cruzi, the agent of human Chagas disease.
246       Using a murine model of infection with Trypanosoma cruzi, the causal agent of Chagas cardiomyop
247 lled intestinal microbiota, neither affected Trypanosoma cruzi, the causal agent of Chagas disease, i
248                                              Trypanosoma cruzi, the causative agent of Chagas disease
249 gi, and more recently the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease
250                                              Trypanosoma cruzi, the causative agent of Chagas disease
251 characterized from the unicellular protozoan Trypanosoma cruzi, the causative agent of Chagas disease
252 the major cysteine protease of the protozoan Trypanosoma cruzi, the causative agent of Chagas disease
253 znidazole is the frontline drug used against Trypanosoma cruzi, the causative agent of Chagas disease
254                                              Trypanosoma cruzi, the causative agent of Chagas disease
255 ted with AT during part of their life cycle: Trypanosoma cruzi, the causative agent of Chagas disease
256                        The release of EVs by Trypanosoma cruzi, the causative agent of Chagas disease
257 st resistance to the intracellular protozoan Trypanosoma cruzi, the causative agent of Chagas' diseas
258   trans-Sialidase is an essential enzyme for Trypanosoma cruzi, the causative agent of Chagas' diseas
259    However, the extent of the repeats within Trypanosoma cruzi, the causative agent of Chagas' diseas
260 alpha-1 displays a trypanocidal role against Trypanosoma cruzi, the causative agent of Chagas' diseas
261  casein kinase II (CKII) substrate (Tc-1) of Trypanosoma cruzi, the causative agent of Chagas' diseas
262  (NMT), an essential and druggable target in Trypanosoma cruzi, the causative agent of Chagas' diseas
263                                              Trypanosoma cruzi, the causing agent of Chagas disease,
264  of the contractile vacuole complex (CVC) of Trypanosoma cruzi, the etiologic agent of Chagas disease
265                          We report here that Trypanosoma cruzi, the etiologic agent of Chagas disease
266          Methods for genetic manipulation of Trypanosoma cruzi, the etiologic agent of Chagas disease
267                                              Trypanosoma cruzi, the etiological agent of Chagas disea
268             A consensus is now emerging that Trypanosoma cruzi, the etiological agent of Chagas disea
269                                              Trypanosoma cruzi, the etiological agent of Chagas disea
270 critical events throughout the life cycle of Trypanosoma cruzi, the etiological agent of Chagas disea
271 ed to date including heteroxenous members of Trypanosoma cruzi, the extracellular Trypanosoma brucei,
272 ves that inhibit TIM's catalytic activity in Trypanosoma cruzi, the parasite that causes Chagas disea
273             During invasion of host cells by Trypanosoma cruzi, the parasite that causes Chagas disea
274                                              Trypanosoma cruzi, the parasitic agent of Chagas disease
275  role of CD43 in the immune response against Trypanosoma cruzi, the protozoan parasite that causes Ch
276                                              Trypanosoma cruzi, the protozoan parasite that causes hu
277                           It is thought that Trypanosoma cruzi, the protozoan that causes Chagas' dis
278 idate clathrin-associated proteins (CAPs) in Trypanosoma cruzi; the cohort includes orthologs of many
279     Cryptosporidium parvum, Leishmania spp., Trypanosoma cruzi, Theileria spp., Toxoplasma gondii and
280             Transmitted by a protozoan named Trypanosoma cruzi, this infection triggers a chronic inf
281 g resistance of the Chagas disease parasite, Trypanosoma cruzi, to current therapies are not well und
282 elivers Gzms into three protozoan parasites (Trypanosoma cruzi, Toxoplasma gondii and Leishmania majo
283 othione and analogues (2-4) as inhibitors of Trypanosoma cruzi TR.
284                                              Trypanosoma cruzi trans-sialidase (TcTS) is a key target
285                                          The Trypanosoma cruzi trans-sialidase (TS) is a unique enzym
286                                   Congenital Trypanosoma cruzi transmission is now estimated to accou
287         The intracellular protozoan parasite Trypanosoma cruzi triggers a robust type I IFN response
288 on host cell contact, the protozoan parasite Trypanosoma cruzi triggers cytosolic Ca(2+) transients t
289  tandem-repeated genes display codon bias in Trypanosoma cruzi, Trypanosoma brucei and Leishmania maj
290 pest insect that has the ability to transmit Trypanosoma cruzi under experimental laboratory conditio
291                 The transition state for the Trypanosoma cruzi uridine phosphorylase (TcUP) reaction
292                      Serological testing for Trypanosoma cruzi was performed at enrollment.
293 telomeres in the South American Trypanosome, Trypanosoma cruzi, we became interested in the telomeric
294                                 The parasite Trypanosoma cruzi which is transmitted by triatomine bug
295 es that the intracellular protozoan parasite Trypanosoma cruzi, which causes heart disease in chronic
296  disease is caused by the protozoan parasite Trypanosoma cruzi, which depends on the production of en
297           Here, using the protozoan parasite Trypanosoma cruzi, which is deficient in strong PAMPs, w
298    Cruzain is the major cysteine protease of Trypanosoma cruzi, which is the causative agent of Chaga
299 m falciparum, Trypanosoma brucei brucei, and Trypanosoma cruzi will be outlined.
300 C(50) within the low nanomolar range against Trypanosoma cruzi, with very high selectivity toward the

 
Page Top